AAAAAA

   
Results: 1-13 |
Results: 13

Authors: NICHOLSON S GOODEN CSR HIRD V MARAVEYAS A MASON P LAMBERT HE MEARES CF EPENETOS AA
Citation: S. Nicholson et al., RADIOIMMUNOTHERAPY AFTER CHEMOTHERAPY COMPARED TO CHEMOTHERAPY ALONE IN THE TREATMENT OF ADVANCED OVARIAN-CANCER - A MATCHED ANALYSIS, Oncology Reports, 5(1), 1998, pp. 223-226

Authors: LAMBERT HE RUSTIN GJS
Citation: He. Lambert et Gjs. Rustin, CONSOLIDATION THERAPY FOR ADVANCED OVARIAN-CANCER, Annals of oncology, 9(2), 1998, pp. 229-229

Authors: LAMBERT HE RUSTIN GJS GREGORY WM NELSTROP AE
Citation: He. Lambert et al., A RANDOMIZED TRIAL OF 5 VERSUS 8 COURSES OF CISPLATIN OR CARBOPLATIN IN ADVANCED EPITHELIAL OVARIAN-CARCINOMA - A NORTH-THAMES OVARY GROUP-STUDY, Annals of oncology, 8(4), 1997, pp. 327-333

Authors: RUSTIN GJS NELSTROP AE CRAWFORD M LEDERMANN J LAMBERT HE COLEMAN R JOHNSON J EVANS H BROWN S OSTER W
Citation: Gjs. Rustin et al., PHASE-II TRIAL OF ORAL ALTRETAMINE FOR RELAPSED OVARIAN-CARCINOMA - EVALUATION OF DEFINING RESPONSE BY SERUM CA125, Journal of clinical oncology, 15(1), 1997, pp. 172-176

Authors: RUSTIN GJS NELSTROP AE TUXEN MK LAMBERT HE
Citation: Gjs. Rustin et al., DEFINING PROGRESSION OF OVARIAN-CARCINOMA DURING FOLLOW-UP ACCORDING TO CA-125 - A NORTH-THAMES-OVARY-GROUP STUDY, Annals of oncology, 7(4), 1996, pp. 361-364

Authors: RUSTIN GJS NELSTROP AE MCCLEAN P BRADY MF MCGUIRE WP HOSKINS WJ MITCHELL H LAMBERT HE
Citation: Gjs. Rustin et al., DEFINING RESPONSE OF OVARIAN-CARCINOMA TO INITIAL CHEMOTHERAPY ACCORDING TO SERUM CA-125, Journal of clinical oncology, 14(5), 1996, pp. 1545-1551

Authors: HARRINGTON KJ HARRISON M BAYLE P EVANS K DUNN PA LAMBERT HE SAIDAN Z LYNN J STEWART JSW
Citation: Kj. Harrington et al., SURGICAL CLIPS IN PLANNING THE ELECTRON BOOST IN BREAST-CANCER - A QUALITATIVE AND QUANTITATIVE-EVALUATION, International journal of radiation oncology, biology, physics, 34(3), 1996, pp. 579-584

Authors: HARRINGTON KJ PANDHA HS KELLY SA LAMBERT HE JACKSON JE WAXMAN J
Citation: Kj. Harrington et al., PALLIATION OF OBSTRUCTIVE NEPHROPATHY DUE TO MALIGNANCY, British Journal of Urology, 76(1), 1995, pp. 101-107

Authors: THOMAS H NASIM MM SARRAF CE ALISON MR LOVE S LAMBERT HE PRICE P
Citation: H. Thomas et al., PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IMMUNOSTAINING - A PROGNOSTIC FACTOR IN OVARIAN-CANCER, British Journal of Cancer, 71(2), 1995, pp. 357-362

Authors: HARRINGTON KJ LAMBERT HE KELLY SA LAI PS PRICE GD
Citation: Kj. Harrington et al., PROSTAGLANDIN-INDUCED CERVICAL DILATATION PRIOR TO INTRACAVITARY RADIOTHERAPY FOR CARCINOMA OF THE CERVIX - A PILOT-STUDY, International journal of gynecological cancer, 4(6), 1994, pp. 404-407

Authors: MARAVEYAS A SNOOK D HIRD V KOSMAS C MEARES CF LAMBERT HE EPENETOS AA
Citation: A. Maraveyas et al., PHARMACOKINETICS AND TOXICITY OF AN YTTRIUM-90-CITC-DTPA-HMFG1 RADIOIMMUNOCONJUGATE FOR INTRAPERITONEAL RADIOIMMUNOTHERAPY OF OVARIAN-CANCER, Cancer, 73(3), 1994, pp. 1067-1075

Authors: OROURKE NP LAMBERT HE
Citation: Np. Orourke et He. Lambert, SECONDARY CYTOREDUCTION - CAN IT BE JUSTIFIED, Journal of clinical oncology, 11(10), 1993, pp. 2050-2051

Authors: HIRD V MARAVEYAS A SNOOK D DHOKIA B SOUTTER WP MEARES C STEWART JSW MASON P LAMBERT HE EPENETOS AA
Citation: V. Hird et al., ADJUVANT THERAPY OF OVARIAN-CANCER WITH RADIOACTIVE MONOCLONAL-ANTIBODY, British Journal of Cancer, 68(2), 1993, pp. 403-406
Risultati: 1-13 |